Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Debt Issuances (2017 - 2025)

Northwest Biotherapeutics' Long-Term Debt Issuances history spans 15 years, with the latest figure at $5.0 million for Q4 2025.

  • Quarterly results put Long-Term Debt Issuances at $5.0 million for Q4 2025, up 150.0% from a year ago — trailing twelve months through Dec 2025 was $12.0 million (down 14.29% YoY), and the annual figure for FY2025 was $12.0 million, down 14.29%.
  • Long-Term Debt Issuances for Q4 2025 was $5.0 million at Northwest Biotherapeutics, up from $2.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $16.1 million in Q4 2021 to a low of $600000.0 in Q1 2022.
  • The 5-year median for Long-Term Debt Issuances is $5.0 million (2022), against an average of $5.5 million.
  • The sharpest move saw Long-Term Debt Issuances tumbled 94.0% in 2022, then surged 1566.67% in 2023.
  • Year by year, Long-Term Debt Issuances stood at $16.1 million in 2021, then crashed by 68.93% to $5.0 million in 2022, then soared by 100.0% to $10.0 million in 2023, then tumbled by 80.0% to $2.0 million in 2024, then skyrocketed by 150.0% to $5.0 million in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at $5.0 million, $2.0 million, and $5.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.